ArticleInvestigational new drugs2017

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.

Muhammad S Beg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.